Market capitalization | $56.31m |
Enterprise Value | $64.35m |
P/E (TTM) P/E ratio | negative |
EV/FCF (TTM) EV/FCF | negative |
EV/Sales (TTM) EV/Sales | 1.36 |
P/S ratio (TTM) P/S ratio | 1.19 |
P/B ratio (TTM) P/B ratio | 5.36 |
Revenue growth (TTM) Revenue growth | -6.27% |
Revenue (TTM) Revenue | $47.29m |
As a Free StocksGuide user, you can view scores for all 6,789 stocks worldwide.
3 Analysts have issued a Apyx Medical Corporation forecast:
3 Analysts have issued a Apyx Medical Corporation forecast:
Mar '25 |
+/-
%
|
||
Revenue | 47 47 |
6%
6%
|
|
Gross Profit | 13 13 |
4%
4%
|
|
EBITDA | -15 -15 |
28%
28%
|
EBIT (Operating Income) EBIT | -15 -15 |
27%
27%
|
Net Profit | -20 -20 |
12%
12%
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Apyx Medical Corp. operates as an energy-based medical technology company. The firm engages in developing, manufacturing, and marketing a range of electrosurgical products and technologies, as well as related medical products used the offices of doctors, surgery centers, and hospitals worldwide. It operates through the following segments: Advanced Energy and Original Equipment Manufacture (OME). The company was founded by Andrew Makrides in 1978 and is headquartered in Clearwater, FL.
Head office | United States |
CEO | Charles Goodwin |
Employees | 220 |
Founded | 1978 |
Website | apyxmedical.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.